This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
2mt5
From Proteopedia
(Difference between revisions)
| (2 intermediate revisions not shown.) | |||
| Line 1: | Line 1: | ||
==Isolated Ring domain== | ==Isolated Ring domain== | ||
| - | <StructureSection load='2mt5' size='340' side='right' caption='[[2mt5 | + | <StructureSection load='2mt5' size='340' side='right'caption='[[2mt5]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
| - | <table><tr><td colspan='2'>[[2mt5]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[2mt5]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Homo_sapiens Homo sapiens]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=2MT5 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=2MT5 FirstGlance]. <br> |
| - | </td></tr><tr id=' | + | </td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">Solution NMR</td></tr> |
| - | <tr id=' | + | <tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=ZN:ZINC+ION'>ZN</scene></td></tr> |
| - | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=2mt5 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=2mt5 OCA], [https://pdbe.org/2mt5 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=2mt5 RCSB], [https://www.ebi.ac.uk/pdbsum/2mt5 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=2mt5 ProSAT]</span></td></tr> |
</table> | </table> | ||
== Function == | == Function == | ||
| - | [ | + | [https://www.uniprot.org/uniprot/APC11_HUMAN APC11_HUMAN] Component of the anaphase promoting complex/cyclosome (APC/C), a cell cycle-regulated E3 ubiquitin ligase that controls progression through mitosis and the G1 phase of the cell cycle. The APC/C complex acts by mediating ubiquitination and subsequent degradation of target proteins: it mainly mediates the formation of 'Lys-11'-linked polyubiquitin chains and, to a lower extent, the formation of 'Lys-48'- and 'Lys-63'-linked polyubiquitin chains. May recruit the E2 ubiquitin-conjugating enzymes to the complex.<ref>PMID:11739784</ref> <ref>PMID:18485873</ref> |
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
| Line 23: | Line 23: | ||
__TOC__ | __TOC__ | ||
</StructureSection> | </StructureSection> | ||
| - | [[Category: | + | [[Category: Homo sapiens]] |
| - | [[Category: Brown | + | [[Category: Large Structures]] |
| - | [[Category: Frye | + | [[Category: Brown NG]] |
| - | [[Category: Jarvis | + | [[Category: Frye JJ]] |
| - | [[Category: Peters | + | [[Category: Jarvis M]] |
| - | [[Category: Petzold | + | [[Category: Peters J]] |
| - | [[Category: Qiao | + | [[Category: Petzold G]] |
| - | [[Category: Royappa | + | [[Category: Qiao R]] |
| - | [[Category: Schulman | + | [[Category: Royappa G]] |
| - | [[Category: Stark | + | [[Category: Schulman B]] |
| - | [[Category: Vanderlinden | + | [[Category: Stark H]] |
| - | [[Category: Watson | + | [[Category: Vanderlinden R]] |
| - | [[Category: Weissman | + | [[Category: Watson ER]] |
| - | + | [[Category: Weissman F]] | |
| - | + | ||
| - | + | ||
Current revision
Isolated Ring domain
| |||||||||||
Categories: Homo sapiens | Large Structures | Brown NG | Frye JJ | Jarvis M | Peters J | Petzold G | Qiao R | Royappa G | Schulman B | Stark H | Vanderlinden R | Watson ER | Weissman F
